Yaprak Seçil
Yaprak Seçil has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Yesim Beckmann
Department of Neurology, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey
6 shared publications - Figen Tokucoglu
Neurology Department, Faculty of Medicine, Balikesir University, 10145 Balikesir, Turkey
5 shared publications - Galip Akhan
IZMIR KATIP CELEBI UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF INTERNAL MEDICINE, DEPARTMENT OF NEUROLOGY
3 shared publications - Mehmet Çelebisoy
Ataturk Research and Training Hospital Izmir, Neurology, Turkey
3 shared publications T. Kurt Incesu
3 shared publications- Cemalettin Ertekin
Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Türkiye
2 shared publications
Latest Publications
- 8 December 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (4) , 716-720
A case of myasthenia gravis emerging after prior diagnosis of CIDP: Clinical challenges in overlapping autoimmune disorders
Chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) are distinct autoimmune neuromuscular disorders that rarely coexist. We present a 52-year-old man with stable CIDP who developed progressive lower limb weakness and facial involvement. Electrophysiological studies revealed neuromuscular junction dysfunction, and elevated acetylcholine receptor antibodies confirmed MG. Treatment with pyridostigmine, intravenous immunoglobulin, and rituximab resulted in clinical stabilization. This case shows the importance of considering overlapping autoimmune disorders in CIDP patients with new or atypical symptoms. Early recognition using electrophysiological and serological tests is important for accurate diagnosis and effective management of coexisting CIDP and MG.
- 8 December 2025
- Published by Ege Journal of Medicine in Ege Tıp Dergisi
- Vol. 64 (4) , 716-720
A case of myasthenia gravis emerging after prior diagnosis of CIDP: Clinical challenges in overlapping autoimmune disorders
Chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) are distinct autoimmune neuromuscular disorders that rarely coexist. We present a 52-year-old man with stable CIDP who developed progressive lower limb weakness and facial involvement. Electrophysiological studies revealed neuromuscular junction dysfunction, and elevated acetylcholine receptor antibodies confirmed MG. Treatment with pyridostigmine, intravenous immunoglobulin, and rituximab resulted in clinical stabilization. This case shows the importance of considering overlapping autoimmune disorders in CIDP patients with new or atypical symptoms. Early recognition using electrophysiological and serological tests is important for accurate diagnosis and effective management of coexisting CIDP and MG.
- Open Access
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 137-142
N-hexane neuropathy: more frequent than expected
Organic solvents that are widely used in industrial production and abused amongst teenagers for recreational purposes may cause some neurological abnormalities including polyneuropathy. Poorly ventilated working environments and working without protective garments are the most common reasons of intoxication. N-hexane toxicity often causes sensorimotor mixed type demyelinating neuropathy, but axonal degeneration is not rare. We report five cases that had mainly axonal motor polyneuropathy due to n-hexane containing glue usage, with clinical and electrophysiological data. Clinical and electrophysiological examinations revealed predominantly motor findings. One patient had delayed P100 potential, two had abnormal conduction in fasciculus gracilis. “Coasting” phenomenon was observed in one patient. Neuropathy due to toxic agents is an important public health problem. Working place conditions must be strictly controlled if toxic materials are present. Patients who had electromyography compatible with polyneuropathy should be questioned for toxic exposure. Asymptomatic workers should also be examined. Patients should be followed for the possibility of “coasting” effect.
- 20 June 2025
- Published by MediHealth Academy in Kastamonu Medical Journal
- Vol. 5 (2) , 137-142
Open AccessN-hexane neuropathy: more frequent than expected
Organic solvents that are widely used in industrial production and abused amongst teenagers for recreational purposes may cause some neurological abnormalities including polyneuropathy. Poorly ventilated working environments and working without protective garments are the most common reasons of intoxication. N-hexane toxicity often causes sensorimotor mixed type demyelinating neuropathy, but axonal degeneration is not rare. We report five cases that had mainly axonal motor polyneuropathy due to n-hexane containing glue usage, with clinical and electrophysiological data. Clinical and electrophysiological examinations revealed predominantly motor findings. One patient had delayed P100 potential, two had abnormal conduction in fasciculus gracilis. “Coasting” phenomenon was observed in one patient. Neuropathy due to toxic agents is an important public health problem. Working place conditions must be strictly controlled if toxic materials are present. Patients who had electromyography compatible with polyneuropathy should be questioned for toxic exposure. Asymptomatic workers should also be examined. Patients should be followed for the possibility of “coasting” effect.
- 1 October 2016
- Published by Elsevier in Neuromuscular Disorders
- Vol. 26, S170
Hereditary inclusion body myopathy in Turkish sisters with a novel mutation in the GNE gene
- 1 October 2016
- Published by Elsevier in Neuromuscular Disorders
- Vol. 26, S170
Hereditary inclusion body myopathy in Turkish sisters with a novel mutation in the GNE gene
- 1 October 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 357, e409-e410
Intracerebral hemorrhage complication after IV thrombolytic treatment
- 1 October 2015
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 357, e409-e410
Intracerebral hemorrhage complication after IV thrombolytic treatment
- Open Access
- 30 December 2014
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 12 (3) , 110-117
Nörolojik Yogun Bakim Izlemi Gerektiren Nöroleptik Malign Sendrom: Dokuz Olgu ile Gözden Geçirme
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-up. In this paper, we report nine cases with NMS followed up in our Neurology Intensive Care Unit over the last three years
- 30 December 2014
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 12 (3) , 110-117
Open AccessNörolojik Yogun Bakim Izlemi Gerektiren Nöroleptik Malign Sendrom: Dokuz Olgu ile Gözden Geçirme
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-up. In this paper, we report nine cases with NMS followed up in our Neurology Intensive Care Unit over the last three years
- 1 June 2014
- Published by Elsevier in Clinical Neurophysiology
- Vol. 125, S302
P956: N-hexane polyneuropathy: clinical and electrophysiological review with five patients
- 1 June 2014
- Published by Elsevier in Clinical Neurophysiology
- Vol. 125, S302
P956: N-hexane polyneuropathy: clinical and electrophysiological review with five patients
- 1 June 2011
- Published by Elsevier in Clinical Neurophysiology
- Vol. 122, S108
P10.16 Deglutition related sympathetic skin responses (SSR) in adult humans
- 1 June 2011
- Published by Elsevier in Clinical Neurophysiology
- Vol. 122, S108
P10.16 Deglutition related sympathetic skin responses (SSR) in adult humans
- 1 October 2010
- Published by Elsevier in Clinical Neurophysiology
- Vol. 121, S285
P30-23 Neuropatic complications of H1N1 vaccination
- 1 October 2010
- Published by Elsevier in Clinical Neurophysiology
- Vol. 121, S285
P30-23 Neuropatic complications of H1N1 vaccination
- 1 May 2008
- Published by Elsevier in Clinical Neurophysiology
- Vol. 119, S117-S118
P184 Anterior tarsal tunnel syndrome
- 1 May 2008
- Published by Elsevier in Clinical Neurophysiology
- Vol. 119, S117-S118
P184 Anterior tarsal tunnel syndrome